Entrectinib price and drug purchase guide after medical insurance in 2024

Enrectinib, this targeted anti-cancer drug forNTRK gene fusion and ROS1-positive non-small cell lung cancer, has attracted the attention of patients and doctors because of its unique efficacy and ability to cross the blood-brain barrier. With the popularity of entrectinib in the Chinese market and its inclusion in the medical insurance catalog, patients are particularly concerned about its price changes. So, by 2024, what will the price of entrectinib be after medical insurance?

First of all, it needs to be made clear that the specific price of entrectinib after medical insurance will be affected by a variety of factors, including different pharmacy pricing and different reimbursement ratios in different places. Therefore, it is impossible to give an exact price data. But generally speaking, after entrectinib is included in medical insurance, its treatment costs will be reduced a lot, which will alleviate a lot of the financial burden on patients. For specific reimbursement ratios, patients should consult their local medical insurance bureau to obtain the most accurate information.

While enjoying medical insurance reimbursement, patients need to pay attention to some restrictions. Usually, patients need to provide relevant disease diagnosis certificates, prescriptions and drug purchase vouchers, etc., to prove that they really need to be treated with entrectinib. In addition, some areas may require patients to undergo approval from a designated medical insurance hospital before they can receive reimbursement. Therefore, before purchasing, patients should learn more about local reimbursement policies and procedures and prepare relevant materials in advance.

For patients with greater financial pressure, purchasing drugs overseas may be an option. For example, the price of the Lao-ASEAN version of entrectinib and the version produced by the Lao Second Pharmaceutical Factory is relatively affordable, around 7,000 to 8,000 yuan per box. However, patients should pay attention to the source and quality of drugs when purchasing to ensure that the drugs they purchase are safe and effective. At the same time, since purchasing drugs overseas involves cross-border transportation and customs inspections, patients also need to pay attention to the transportation safety and compliance of drugs.

Overall, the inclusion of entrectinib in medical insurance brings more treatment options and financial support to patients. However, patients need to understand local reimbursement policies and conditions to obtain the most detailed information. For patients who purchase drugs overseas, please be sure to choose a guaranteed and formal drug purchasing channel to ensure the safety and effectiveness of the medication.